They are both given as a subcutaneous injection. The most common side effects for Evenity are joint pain and headaches, while ...

Prolia which would be soon available on the ... of bones that leads to an increased risk of fractures. The twice-yearly injection offers hope to the more than 100,000 people - most of whom are ...

Amgen's osteoporosis drug, Prolia (denosumab), could have a new use after it showed positive results in glucocorticoid-induced disease. Prolia is already well established, with sales of more than ...

Organon (NYSE:OGN) and partner Shanghai Henlius Biotech said the FDA has accepted the Biologics License Application for HLX14, a biosimilar of Amgen’s (AMGN) Prolia/Xgeva, also known as denosumab.

Taken alongside Prolia/Xgeva, the brands account for well over 40% of Amgen's current revenues. Other companies working on biosimilar versions of denosumab include Samsung Bioepis, Celltrion, and ...